Prenetics CEO Danny Yeung to Deliver Keynote Address at Token 2049 Singapore
– Keynote presentation titled: “IM8: The World’s Fastest-Growing Supplement Brand Powering Our Bitcoin Treasury”
– Prenetics presently possesses 246 BTC, boasting a Net Asset Value (NAV) of $28 million
– Prenetics maintains $63.5 million in cash holdings1
CHARLOTTE, N.C., Sept. 30, 2025 — Prenetics Global Limited (NASDAQ: PRE), a prominent consumer health sciences firm, declared today that its Chief Executive Officer, Danny Yeung, is slated to give a keynote address at Token 2049, a leading global crypto and blockchain conference held in Singapore.
Yeung’s presentation is set for Thursday, October 2, 2025, where he will join a distinguished roster of international visionaries, innovators, and investors. His keynote, titled “IM8: The World’s Fastest-Growing Supplement Brand Powering Our Bitcoin Treasury,” will underscore Prenetics’ distinct standing as one of the few rapidly expanding operational businesses simultaneously developing a substantial digital asset treasury. In contrast to most digital asset treasury (DAT) approaches adopted by entities lacking a primary operational business, Prenetics distinguishes itself through IM8’s rapid expansion, which enables the systematic daily acquisition of 1 Bitcoin to consistently bolster its balance sheet.
Additionally, the address will showcase IM8’s remarkable progress—poised to exceed $100 million in annual recurring revenue within less than 12 months of its introduction, marking an unparalleled achievement within the supplement sector and a strong endorsement of its groundbreaking model at the convergence of health and financial prosperity.
Bitcoin Treasury Strategy Initiative:
In June 2025, earlier this year, Prenetics revealed its corporate Bitcoin strategy implementation. This initiative involves dedicating a significant portion of the Company’s balance sheet to Bitcoin and incorporating Bitcoin throughout its operational activities.
The strategy commenced with an initial acquisition of 187.42 BTC for approximately USD $20 million, at an average cost of $106,712 per BTC. Since August 1, 2025, Prenetics has maintained a structured, programmatic method, procuring Bitcoin on a daily basis. As of the current date, the Company possesses 248.42 BTC, acquired at an approximate average price of $108,600, thereby highlighting the extensive scope and dedication of its treasury management plan.
Moving forward, Prenetics intends to persist with its daily procurement of one Bitcoin until the close of 2025, with projections to accelerate the rate of accumulation in 2026 as operational cash flow steadily improves. Current data regarding the Company’s Bitcoin holdings is accessible at .
1Denotes current assets, comprising estimated proceeds of $46.3 million from the divestiture of ACT Genomics to be settled in cash, cash and cash equivalents amounting to $17.2 million, financial assets valued at fair value through profit or loss of $10.5 million, and trade receivables of $1.8 million, among other accounting entries classified under current assets as of June 30, 2025.
About Prenetics
Prenetics (NASDAQ:PRE), a prominent health sciences enterprise, is committed to furthering consumer and clinical health. Our consumer-focused efforts are spearheaded by IM8, a rapidly expanding health and wellness brand; Europa, one of the largest sports distribution firms in the USA; and CircleDNA, a premier direct-to-consumer DNA testing service. Each division within Prenetics collectively amplifies our worldwide influence on health, reflecting our dedication to ‘enhancing life through science’. For additional information about Prenetics, please visit prenetics.com.
About Token 2049
Token 2049 stands as the foremost cryptocurrency event, convened annually in Singapore, gathering leading global founders, executives, investors, developers, and media to deliberate on worldwide advancements and tendencies within the digital asset sector.
Investor Relations Contact:
Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
